Advances in Monitoring and Management of Coagulation in Cardiac Surgery: Implications for Anesthetic Practice

Lauren Stephen^*
*Correspondence: Lauren Stephen, Department of Anesthesiology and Pain Medicine, University of Freiburg, Fahnenbergplatz, 79085 Freiburg im Breisgau, Germany, Email:

Keywords

Anesthetic practice • Cardiac surgery • Surgical patients

Introduction

Cardiac surgery is a complex and high-risk procedure that often requires meticulous management of coagulation to ensure optimal patient outcomes. Coagulopathy, characterized by abnormal clotting or bleeding tendencies, is a significant concern during cardiac surgery due to the intricate interplay of surgical trauma, cardiopulmonary bypass (CPB), and systemic inflammation. Anesthetic providers play a crucial role in monitoring and managing coagulation during these procedures, as they are responsible for maintaining hemostasis and minimizing perioperative complications. In recent years, significant advances have been made in the monitoring and management of coagulation in cardiac surgery, leading to improved patient outcomes and reduced morbidity and mortality rates.

These advancements have been driven by a better understanding of the coagulation cascade, the introduction of point-of-care testing (POCT) devices, and the development of targeted management strategies. Traditionally, laboratory tests such as prothrombin time (PT) and activated partial thromboplastin time (aPTT) have been used to assess coagulation status. However, these tests have limitations in capturing the dynamic changes that occur during cardiac surgery [1-3]. The introduction of POCT devices, such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM), has revolutionized coagulation monitoring. These tests provide real-time information on clot formation, strength, and lysis, allowing anesthetic providers to make immediate and targeted interventions based on individual patient needs.

Literature Review

Traditional laboratory tests such as prothrombin time (PT) and activated partial thromboplastin time (aPTT) have limitations in reflecting the dynamic changes in coagulation during cardiac surgery. In recent years, point-of-care testing (POCT) devices, such as thromboelastography (TEG) and rotational thromboelastometry (ROTEM), have gained popularity. These tests provide real-time assessment of clot formation, strength, and lysis, allowing for targeted and individualized coagulation management. Transfusion of blood products has conventionally been the mainstay of coagulation management in cardiac surgery. However, emerging evidence suggests that a restrictive transfusion strategy, guided by individual patient characteristics and point-of-care testing results, can be safe and effective. The use of antifibrinolytic agents, such as tranexamic acid, has shown to reduce bleeding and transfusion requirements. Additionally, pharmacological interventions targeting platelet function, such as desmopressin and antiplatelet agents, have been utilized to minimize bleeding risks while ensuring hemostasis.

Management strategies for coagulation in cardiac surgery have also evolved. Traditional approaches focused on the transfusion of blood products to maintain hemostasis. However, recent evidence has shown that a restrictive transfusion strategy, guided by individual patient characteristics and POCT results, can be just as effective and reduce the risks associated with transfusion. Moreover, the use of antifibrinolytic agents, such as tranexamic acid, has proven to be beneficial in reducing bleeding and transfusion requirements. Pharmacological interventions targeting platelet function, such as desmopressin and antiplatelet agents, have also been utilized to minimize bleeding risks while ensuring adequate hemostasis.

Discussion

Implications for anesthetic practice

The advancements in monitoring and management of coagulation in cardiac surgery have significant implications for anesthetic practice. Anesthesiologists play a crucial role in perioperative coagulation management, and understanding these implications is essential for providing optimal patient care. Here are some key implications for anesthetic practice:

Tailored transfusion strategies: The use of point-of-care testing (POCT) devices, such as TEG and ROTEM, allows anesthesiologists to assess coagulation status in real-time. This information helps guide transfusion decisions, enabling a more tailored and individualized approach to transfusion. Anesthetic providers can avoid unnecessary blood product transfusions, minimizing the risks associated with transfusion reactions and transfusionrelated complications [4,5].

Personalized coagulation management: With the availability of POCT devices, anesthesiologists can obtain a comprehensive understanding of an individual patient's coagulation profile. This enables personalized coagulation management based on specific patient characteristics, surgical procedure, and coagulation status. Anesthetic providers can intervene promptly and adjust management strategies accordingly, optimizing hemostasis and minimizing the risk of bleeding or thrombotic complications.

Use of antifibrinolytic agents: The introduction of antifibrinolytic agents, such as tranexamic acid, has had a significant impact on coagulation management in cardiac surgery. Anesthesiologists should be familiar with the appropriate dosing, timing, and administration techniques for these agents. Tranexamic acid has shown to reduce bleeding and transfusion requirements, and its use can help achieve effective hemostasis while minimizing the risk of excessive clot formation.

Platelet modulating agents: Pharmacological interventions targeting platelet function have become an integral part of coagulation management in cardiac surgery. Anesthetic providers need to be knowledgeable about the use of platelet modulating agents, such as desmopressin and antiplatelet medications, and their implications for anesthesia. These agents can help mitigate bleeding risks while ensuring adequate platelet function, maintaining hemostasis during and after the surgical procedure.

Collaborative multidisciplinary approach: Coagulation management in cardiac surgery requires a multidisciplinary approach involving anesthesiologists, surgeons, perfusionists, and hematologists. Anesthetic providers need to collaborate closely with other healthcare professionals to develop standardized protocols, ensure seamless communication, and optimize patient outcomes. Multidisciplinary discussions and regular team meetings facilitate the exchange of knowledge and expertise, promoting a comprehensive and coordinated approach to coagulation management [6].

The advances in monitoring and management of coagulation in cardiac surgery have profound implications for anesthetic practice. Anesthesiologists must be well-versed in the interpretation of POCT results, use tailored transfusion strategies, and have a comprehensive understanding of the appropriate use of antifibrinolytic agents and platelet modulating drugs. By adopting a collaborative multidisciplinary approach, anesthetic providers can contribute to optimizing coagulation management, reducing complications, and improving patient outcomes in cardiac surgery.

Conclusion

Advances in monitoring and management of coagulation in cardiac surgery have revolutionized the field, enabling personalized and targeted interventions to optimize patient outcomes. Anesthetic practice has evolved to encompass the use of point-of-care testing, restrictive transfusion strategies, and pharmacological interventions to minimize bleeding risks and ensure hemostasis. Anesthesiologists should remain up-to-date with these advancements and collaborate with other healthcare professionals to provide optimal coagulation management in cardiac surgery. Further research is needed to refine and individualize coagulation management strategies for specific patient populations and surgical procedures.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Eckenhoff, Roderic G., Mervyn Maze, Zhongcong Xie and Deborah J. Culley, et al. "Perioperative neurocognitive disorder: State of the preclinical science." Anesthesiology 132 (2020): 55-68.

Google Scholar, Crossref, Indexed at

2. Liu, Yang, Huiqun Fu and Tianlong Wang. "Neuroinflammation in perioperative neurocognitive disorders: From bench to the bedside." CNS Neurosci Ther 28 (2022): 484-496.

Google Scholar, Crossref, Indexed at

3. Newman, Mark F., Jerry L. Kirchner, Barbara Phillips-Bute and Vincent Gaver, et al. "Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery." N Engl J Med 344 (2001): 395-402.

Google Scholar, Crossref, Indexed at

4. Han, Kelsey, Jordan D. Bohnen, Thomas Peponis and Myriam Martinez, et al. "The surgeon as the second victim? results of the boston intraoperative adverse events surgeons' attitude (bisa) study." J Am Coll Surg 224 (2017): 1048-1056

Google Scholar, Crossref, Indexed at

5. Baker, David W., Ruth M. Parker, Mark V. Williams and Wendy C. Coates, et al. "Use and effectiveness of interpreters in an emergency department." JAMA 275 (1996): 783-788.

Google Scholar, Crossref, Indexed at

6. Mort, Thomas C. "Continuous airway access for the difficult extubation: The efficacy of the airway exchange catheter." Anesth Analg 105 (2007): 1357-1362.

Google Scholar, Crossref, Indexed at